Bull case
BG would need investors to value it at roughly 56x earnings — about 41x more generous than today's 15x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
Wall Street verdict, consensus price target, and analyst rating breakdown — everything needed to frame the risk/reward at today's price.
Three scenarios for where BG stock could go
BG would need investors to value it at roughly 56x earnings — about 41x more generous than today's 15x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
At 21x on FY1 earnings, the base case reflects a reasonable but not stretched valuation. It prices in continued growth without assuming an exceptional setup.
The bear case reflects a scenario where earnings shortfalls or multiple compression combine to materially reduce the stock from its current level.
Not financial advice. Model confidence reflects internal scenario assumptions, not a guarantee of returns. Past performance does not predict future results.

Bunge Global is a global agribusiness and food company that processes and trades agricultural commodities like soybeans, grains, and vegetable oils. It makes money primarily through its Agribusiness segment — which handles commodity trading, processing, and logistics — and its Refined and Specialty Oils segment that sells packaged oils and fats to food manufacturers and retailers. The company's key advantage is its integrated global supply chain network that connects farmers to end markets, providing scale and logistical efficiency in a capital-intensive industry.
Quarterly beat-or-miss track record against analyst estimates, plus forward revenue and EPS outlook for the next two fiscal years.
| Quarter | EPS (Actual / Est) | EPS Surprise | Revenue (Actual / Est) | Rev Surprise |
|---|---|---|---|---|
| Q3 2025 | $1.31/$1.09 | +20.2% | $12.8B/$12.2B | +4.3% |
| Q4 2025 | $2.27/$1.94 | +17.0% | $22.2B/$14.7B | +50.4% |
| Q1 2026 | $1.99/$1.81 | +9.9% | $23.8B/$22.6B | +5.1% |
| Q2 2026 | $1.83/$0.97 | +88.7% | $21.9B/$23.4B | -6.5% |
BG beat EPS estimates in 4 of 4 tracked quarters. A perfect track record raises the bar for the upcoming report.
Product and geographic revenue mix from the latest annual disclosure, with year-over-year growth by segment.
Latest annual revenue by segment or product family
Tap, hover, or focus a slice to inspect segment detail.
Latest annual revenue by reported region
Tap, hover, or focus a slice to inspect segment detail.
Current multiples compared to the S&P 500, the company's sector, and its own five-year average.
Fair value est. $73 — implies -41.2% from today's price.
| Metric | BG | S&P 500 | Consumer Defensive | 5Y Avg BG |
|---|---|---|---|---|
| Forward PE | 14.6x | 19.1x-23% | 14.6x | — |
| Trailing PE | 25.6x | 25.2x | 19.6x+30% | 10.2x+151% |
| PEG Ratio | — | 1.75x | 1.85x | — |
| EV/EBITDA | 22.8x | 15.3x+50% | 11.4x+100% | 9.0x+155% |
| Price/FCF | — | 21.3x | 15.7x | 14.0x |
| Price/Sales | 0.3x | 3.1x-89% | 0.8x-59% | 0.2x+52% |
| Dividend Yield | 2.19% | 1.88% | 2.73% | 2.67% |
Forward P/E and PEG reflect analyst consensus estimates. Historical averages use trailing ratios where forward data is unavailable.S&P 500 and sector benchmarks both use trailing median P/E — similar readings indicate the broader index and sector are priced alike.
Open valuation toolBG returns 4.4% of market cap to shareholders annually.
Revenue, margins, and cash generation
ROIC, leverage, and debt serviceability
~141.2 years to full repayment at current FCF run-rate
How capital is returned to owners
All figures from the trailing twelve months. ROIC uses invested capital (equity + net debt).
Open full ratios pageKey factors that could pressure the stock price, compress the multiple, or weigh on future results.
AI analysis · updated April 29, 2026
Bunge (BG) has a significant debt load, with a net debt to EBITDA ratio reported as high as 5.7x, considerably higher than management's claims of 1.9x. This excessive leverage exposes the company to greater market volatility and financial strain.
Bunge has experienced a cash flow deficit of $1.6 billion after capital expenditures and investments, indicating potential issues with financial health and future shareholder returns. The company is also noted as not being cash flow generative, with a negative Free Cash Flow/Revenue (LTM) of -1.2%.
The recent $10.6 billion acquisition of Viterra is under scrutiny, with concerns that it has not delivered expected synergies. Bunge's 2025 EBITDA projections for Viterra missed by 24%, and Viterra's revenue declined approximately 16.7%.
Bunge's valuation metrics suggest it may be overvalued, with a P/E ratio close to its 5-year high and a P/S ratio near a 10-year high. Some analyses suggest the fair price of Bunge Global SA (BG) is between $83.89 to $106.80, making it overvalued at current prices.
The ongoing conflict in the Middle East is causing disrupted global trade flows, logistics costs, and supply chains. This directly impacts Bunge's Grain Merchandising segment through ocean freight dynamics and increased bunker fuel costs.
While BG Group historically mitigated commodity price exposure through long-term contracts and hedging, changes in oil and gas prices could still impact operating profit. Current market conditions, including significant spikes in bunker fuel costs, highlight this vulnerability.
The massive Viterra merger presents significant financial and operational execution risks that could affect Bunge's performance.
Bunge's ROIC of 3.8% is less than its weighted average cost of capital, suggesting potential inefficiencies in capital utilization.
These are risk mechanisms, not predictions. The key question is which would force a cut to earnings estimates or a lower multiple than the market currently prices in.
Structural drivers behind the upside case and why the stock could outperform over the next 12 months.
AI analysis · updated April 29, 2026
The completion of the Viterra merger in July 2025 is a significant driver for the bull case. This integration is expected to create a larger, more diversified agribusiness with enhanced origination, processing, and trading capabilities.
Bunge has raised its synergy expectations from the Viterra merger, indicating confidence in its ability to achieve cost savings and revenue enhancements. The company has outlined a strategic growth plan, targeting at least $15 of EPS by 2030.
Analysts generally hold a positive view on BG stock, with a consensus 'Buy' rating. Several analysts have raised their price targets, indicating meaningful upside from current levels.
Bunge recently reported a significant earnings per share (EPS) beat for Q1 2026, exceeding expectations by over 100%. The company also raised its full-year 2026 adjusted EPS guidance, bolstering investor confidence.
Bunge has committed to returning at least 50% of discretionary cash flow to shareholders and has approved a new $3 billion share repurchase plan. This focus on capital returns is attractive to investors.
A real bull case compounds — each driver matters most when it strengthens margins, supports capital returns, and keeps the company above the market's minimum growth bar simultaneously.
52-week range context and price returns across multiple time horizons. Dividend contribution is shown separately in the Capital Return section.
Range context matters because valuation compression and earnings misses rarely hit from the same starting point. A stock already far below its high can still fall, but it is no longer carrying the same embedded optimism as one pressing a fresh peak.
Valuation, growth, and margin comparison against the closest publicly traded peers for this company.
| Company | Mkt Cap | Fwd PE | Rev Grw | Margin | Rating | Upside |
|---|---|---|---|---|---|---|
BG BG Bunge Global S.A. | $24.5B | 14.6x | +18.3% | 0.9% | Buy | +6.0% |
ADM ADM Archer-Daniels-Midland Company | $37.6B | 18.7x | -2.2% | 1.3% | Hold | -23.1% |
ING INGR Ingredion Incorporated | $6.7B | 9.5x | -1.1% | 10.1% | Hold | +16.8% |
CF CF CF Industries Holdings, Inc. | $18.4B | 8.5x | +0.2% | 23.7% | Buy | -9.1% |
MOS MOS The Mosaic Company | $7.5B | 16.1x | +3.3% | 10.5% | Hold | +32.6% |
TSN TSN Tyson Foods, Inc. | $24.2B | 17.5x | +2.2% | 0.8% | Buy | +3.2% |
This peer comparison reflects companies with similar business models, product lines, or market positioning, supplemented by industry grouping when direct matches are limited.
BG returns 4.3% annually — 2.11% through dividends and 2.2% through buybacks.
Yield, cadence, and growth quality
How much per-share support comes from repurchases
| Year | Div / Share | YoY Grw | BB Yield | Total Yield |
|---|---|---|---|---|
| 2027 | $0.72 | -74.8% | — | — |
| 2026 | $2.86 | — | — | — |
| 2025 | $2.78 | +2.9% | 3.7% | 6.8% |
| 2024 | $2.70 | +5.0% | 10.0% | 13.4% |
| 2023 | $2.58 | +12.0% | 3.9% | 6.5% |
Common questions answered from live analyst data and company financials.
Bunge Global S.A. (BG) is rated Buy by Wall Street analysts as of 2026. Of 25 analysts covering the stock, 21 rate it Buy or Strong Buy, 4 rate it Hold, and 0 rate it Sell or Strong Sell. The consensus 12-month price target is $134, implying +6.0% from the current price of $126.
The Wall Street consensus price target for BG is $134 based on 25 analyst estimates. The high-end target is $150 (+19.0% from today), and the low-end target is $117 (-7.2%). The base case model target is $184.
BG trades at 14.6x times forward earnings. The stock's valuation is broadly in line with the broader market. Based on current multiples versus the peer group, the relative model signals significantly overvalued. Whether the stock is over or undervalued ultimately depends on whether consensus earnings estimates are achievable.
The primary risks for BG in 2026 are: (1) High Leverage and Debt — Bunge (BG) has a significant debt load, with a net debt to EBITDA ratio reported as high as 5. (2) Capital Deficit and Cash Flow Issues — Bunge has experienced a cash flow deficit of $1. (3) Acquisition Underperformance — The recent $10. Each factor has the potential to pressure earnings or compress the stock's valuation multiple.
Analyst consensus estimates BG will report consensus revenue of $95.3B (+18.3% year-over-year) and EPS of $5.68 (+62.2% year-over-year) for the upcoming fiscal year. The following year, analysts project $111.2B in revenue.
A confirmed upcoming earnings date for BG is not yet available. Check the Earnings section above for the most recent quarterly report dates and forward estimates.
Bunge Global S.A. (BG) generated $112M in free cash flow over the trailing twelve months — a free cash flow margin of 0.1%. BG returns capital to shareholders through dividends (2.1% yield) and share repurchases ($551M TTM).